CAS 2055517-66-1

Tubulin polymerization-IN-15

Description:

Tubulin polymerization-IN-15, identified by its CAS number 2055517-66-1, is a small molecule inhibitor that specifically targets tubulin polymerization, a critical process in cell division and cytoskeletal dynamics. This compound is part of a broader class of agents that disrupt microtubule formation, which can have significant implications in cancer therapy, as many cancer cells rely on proper microtubule function for proliferation. The characteristics of Tubulin polymerization-IN-15 include its ability to bind to tubulin, thereby preventing the assembly of microtubules and potentially leading to cell cycle arrest and apoptosis in rapidly dividing cells. Additionally, it may exhibit selectivity for certain cancer types, making it a candidate for targeted therapies. The compound's efficacy, pharmacokinetics, and toxicity profile are subjects of ongoing research, as understanding these parameters is crucial for its development as a therapeutic agent. Overall, Tubulin polymerization-IN-15 represents a promising avenue in the search for effective cancer treatments through the modulation of cytoskeletal dynamics.

Formula: C₁₈H₁₇N₃O₄

Synonyms:

• Tubulin polymerization-IN-15
• Methanone, (2-phenyl-2H-1,2,3-triazol-4-yl)(3,4,5-trimethoxyphenyl)-

Tubulin polymerization-IN-15

CAS: 2055517-66-1

Tubulin polymerization-IN-15 (compound 4) is a highly effective inhibitor of tubulin polymerization, with significant potential in cancer research [1].

Formula: C₁₈H₁₇N₃O₄

Color and Shape: Solid

Molecular weight: 339.35

Ref: TM-T61069